We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$51.6B
AUM Growth
+$2.05B
Cap. Flow
-$2.14B
Cap. Flow %
-4.14%
Top 10 Hldgs %
20.82%
Holding
2,982
New
222
Increased
942
Reduced
1,589
Closed
180

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$364M
2
EZU icon
iShare MSCI Eurozone ETF
EZU
+$274M
3
NVDA icon
NVIDIA
NVDA
+$243M
4
NKE icon
Nike
NKE
+$215M
5
CDW icon
CDW
CDW
+$209M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$507M
2
INTU icon
Intuit
INTU
+$197M
3
LLY icon
Eli Lilly
LLY
+$186M
4
A icon
Agilent Technologies
A
+$185M
5
EXAS
Exact Sciences
EXAS
+$174M

Sector Composition

Rank Sector Weight
1 Technology 25.2%
2 Consumer Discretionary 13.49%
3 Healthcare 12.95%
4 Financials 12.4%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNT icon
2826
Cognyte Software
CGNT
$692M
-28,268
Closed -$786K
CKPT
2827
DELISTED
Checkpoint Therapeutics
CKPT
-2,614
Closed -$82K
CODX
2828
Co-Diagnostics
CODX
$5.49M
-392
Closed -$112K
CRBP icon
2829
Corbus Pharmaceuticals
CRBP
$184M
-1,197
Closed -$71K
CSTE icon
2830
Caesarstone
CSTE
$104M
-10,341
Closed -$142K
CVE icon
2831
Cenovus Energy
CVE
$55B
-43,379
Closed -$326K
CWBC
2832
Community West Bancshares
CWBC
$691M
-15,422
Closed -$284K
CYCN icon
2833
Cyclerion Therapeutics
CYCN
$16.7M
-602
Closed -$34K
DHX icon
2834
DHI Group
DHX
$166M
-27,328
Closed -$92K
DSP icon
2835
Viant Technology
DSP
$264M
-4,351
Closed -$230K
EEX
2836
DELISTED
Emerald Holding
EEX
-12,533
Closed -$69K
EGAN icon
2837
eGain
EGAN
$203M
-10,142
Closed -$96K
ELMD icon
2838
Electromed
ELMD
$351M
-12,903
Closed -$136K
FENC icon
2839
Fennec Pharmaceuticals
FENC
$444M
-11,004
Closed -$68K
FLNT
2840
Fluent
FLNT
$123M
-3,293
Closed -$81K
FTI icon
2841
TechnipFMC
FTI
$29.5B
-22,960
Closed -$177K
GALT icon
2842
Galectin Therapeutics
GALT
$316M
-18,928
Closed -$41K
GIC icon
2843
Global Industrial
GIC
$1.5B
-5,688
Closed -$234K
CBIO
2844
Crescent Biopharma
CBIO
$620M
-611
Closed -$184K
GNPX icon
2845
Genprex
GNPX
$2.26M
0
-$60K
GNSS icon
2846
Genasys
GNSS
$76.1M
-16,347
Closed -$109K
GORO icon
2847
Goldgroup Mining Inc.
GORO
$184M
-32,502
Closed -$86K
GYRE icon
2848
Gyre Therapeutics
GYRE
$704M
-1,442
Closed -$55K
HIFS icon
2849
Hingham Institution for Saving
HIFS
$684M
-708
Closed -$201K
HROW icon
2850
Harrow
HROW
$1.47B
-11,182
Closed -$75K

Similar funds

VOYA Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, VOYA Investment Management held 2,982 positions worth $51.6B, up 4.1% from $49.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

VOYA Investment Management withdrew a net $2.14B in Q2 2021, closing 180 positions and reducing 1,589 holdings. Its most notable exit was Vanguard Russell 1000 Growth ETF, an estimated $8.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, VOYA Investment Management opened a new position in iShare MSCI Eurozone ETF worth $273M.

  • VOYA Investment Management's largest Q2 2021 buy was iShare MSCI Eurozone ETF: 5,524,883 shares worth $273M.
  • VOYA Investment Management added most to Adobe in Q2 2021, an estimated $364M increase.
  • VOYA Investment Management's biggest Q2 2021 reduction was Apple, cutting an estimated $507M.
  • VOYA Investment Management fully exited Vanguard Russell 1000 Growth ETF in Q2 2021, selling an estimated $8.12M.
  • VOYA Investment Management's ten largest holdings make up 21% of its $51.6B portfolio in Q2 2021.
  • VOYA Investment Management opened 222 new positions and closed 180 in Q2 2021.
  • VOYA Investment Management's portfolio value rose 4.1% quarter-over-quarter to $51.6B.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.